Skip to main content

VSTM

Stock
Health Care
Biotechnology

Performance overview

VSTM Price
Price Chart

Forward-looking statistics

Beta
2.30
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Company info

SectorHealth Care
IndustryBiotechnology
Employees73
Market cap$86.1M

Fundamentals

Enterprise value$187.3M
Revenue$10.0M
Revenue per employee
Profit margin0.00%
Debt to equity-2.37

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$3.36
Dividend per share
Revenue per share$0.24
Avg trading volume (30 day)$13M
Avg trading volume (10 day)$17M
Put-call ratio

Macro factor sensitivity

Growth-5.2
Credit+6.8
Liquidity+5.7
Inflation-11.1
Commodities-4.3
Interest Rates-3.6

Valuation

Dividend yield0.00%
PEG Ratio-1.90
Price to sales26.38
P/E Ratio-1.90
Enterprise Value to Revenue18.73
Price to book-8.18

Upcoming events

Next earnings dayMay 14, 2025
Next dividend day
Ex. dividend day

News

VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval

Verastem Oncology jumps 22% on FDA nod for Avmapki Fakzynja, the first approved KRAS-mutant LGSOC therapy, with strong early data in a pancreatic cancer study.

Zacks Investment Research (May 28, 2025)
Why Is Cancer-Focused Verastem Oncology Stock Trading Higher On Tuesday?

On Monday, the FDA accepted for review the New Drug Application under the accelerated approval pathway for Verastem Oncology's VSTM avutometinib.

Benzinga (December 31, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free